In a landmark study in children "and teenagers with type 1 diabetes, JDRF-funded Researchers At The University That of Cambridge showed using a first-generation artificial pancreas system overnight Cdn Lower the risk of low blood sugar emergencies while sleeping, and at the Same Time Improve Diabetes Control.
Results from the studies are published in The February 5, 2010 Issue of The Lancet, available online at www.thelancet.com.
The trials tested the safety and effectiveness of a first-generation artificial pancreas system used overnight in a hospital setting with participants between 5 and 18 years of age with type 1 diabetes. The system combined commercially available blood glucose sensors and insulin pumps, controlled by a sophisticated computer program that determined insulin dosage based on blood glucose levels while the participants slept.
Maintaining recommended blood sugar levels overnight is a major issue for people with type 1 diabetes - and particularly for the families of children with diabetes - because of the possibility of blood glucose dropping dangerously low during sleep and going unnoticed, which can lead to seizures, coma, and in Some boxes Be fatal.
Notably, The Cambridge study showed That the Children and teenagers Spent Twice as Much Time "during the night Blood Glucose Levels Within Targeted When Their diabetes WAS produit With The artificial pancreas system Than When They Followed Conventional" manual "therapy. And Low Blood Sugar Were minimized.
0 comments:
Post a Comment